Replies to post #562289 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Biosect, I certainly hope you're right, I simply don't think that capacity with manual manufacturing of the vaccine is sufficient to even start the ball rolling in more than the U.K. by itself. On approval I've got to believe that brain surgeons and Oncologists who're alert to the news from JAMA Oncology and other presentations have been properly preserving tumors which should create a big initial demand. I realize that not everyone would know what we have going, but I believe enough would to create a substantial demand day one.

Without FlaskWorks units I've got to believe that numbers go into the tens of thousands wanting the vaccine on a monthly basis, at under 4 batches a month per cleanroom I just doubt the requirements can be met from day one, yet alone many months later when off label demand will be added to GBM.

Gary

[kabunushi]

They don't have the cash to contract for thousands of patients worth of clean rooms yet. Once approved, yes, then bank loans can be arranged, especially as they start to show actual cash flow. But bank financing requires approval and proof that the cash income stream is not in any doubt.